Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes

NCT: NCT01939834 · TERMINATED

NCT IDNCT01939834
StatusTERMINATED
Start Date2013-12
Completion2014-01
SponsorSue Brown (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to use an Advisory/Automated Adaptive (AAA) or Closed-Loop Control (CLC) system for insulin delivery in adults with Type 1 Diabetes (T1DM) in an outpatient setting to evaluate the system's ability to significantly improve blood glucose levels. A component of this study evaluated AAA or CLC Control overnight only in 5 consecutive overnights in a cross-over trial with sensor-augmented pump therapy occurring prior to or following CLC overnight. Another component of this study planned evaluating if the AAA Control system run on the Diabetes Assistant (DiAs) system can prevent hypoglycemia during and following exercise more efficiently during a 40 hour trial this part of the trial was not conducted due to a preference for overnight only configuration in pilot testing. This protocol represents a culmination of prior clinical trials in development of this AAA system and benefits from the synthesis of those components.

Frequently Asked Questions

What is Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes?

Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes is a clinical trial registered under NCT01939834. Current status: TERMINATED.

What is the status of NCT01939834?

The current status of NCT01939834 (Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes) is: TERMINATED.

When did Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes start?

Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes started on 2013-12.

Related Devices

PMA P250012Sensor, Glucose, Invasive, Component of automated insulin delivery systemMedtronic Minimed, Inc. PMA P130007Pump, infusion, insulin, to be used with invasive glucose sensorAnimas Corp. PMA P140015Pump, infusion, insulin, to be used with invasive glucose sensorTandem Diabetes Care, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑